Cargando…
The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
AIMS: Many sarcoidosis patients experience a reduction in health-related quality of life (HRQoL) and a majority of patients report fatigue. Historically, drug trials in sarcoidosis have focused on changes in chest radiographs, lung function parameters and biomarkers, while HRQoL and fatigue have not...
Autores principales: | Vis, Roeland, van de Garde, Ewoudt M.W., Grutters, Jan C., Korenromp, Ingrid H.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488574/ https://www.ncbi.nlm.nih.gov/pubmed/31996355 http://dx.doi.org/10.1183/16000617.0057-2019 |
Ejemplares similares
-
GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use
por: Vis, Roeland, et al.
Publicado: (2015) -
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
por: Spoorenberg, Simone MC, et al.
Publicado: (2014) -
ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis Patients
por: Karakaya, Bekir, et al.
Publicado: (2022) -
Establishing a Diagnosis of Pulmonary Sarcoidosis
por: Grutters, Jan C.
Publicado: (2023) -
Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study
por: Wittermans, Esther, et al.
Publicado: (2023)